Xtant Medical postpones Q3 2017 financial results release: 3 insights

Spinal Tech

Xtant Medical postponed its Nov. 8, 2017, release of third quarter financial results.

Here are three insights:

 

1. Along with postponing the financial results, the medical device manufacture also rescheduled the following conference call, scheduled for Nov. 9.

 

2. Xtant plans to release its third quarter 2017 financial results by Nov. 20 in conjunction with the filing of its 10-Q.

 

3. Xtant develops, manufactures and markets regenerative medicine products, as well as orthopedic and neurological devices. Earlier this month, the company entered into a distribution agreement with Curasan, adding synthetic scaffolds to its biologics portfolio.

 

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers